Frontlight ResearchEarly access
Thalassaemia trials in Nigeria
1 of 2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in NigeriaA Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
- Where
- Abuja, Ibadan, Ituku-Ozalla, Kaduna, Kano, Lagos
- Age
- 2 years and over
- People
- 480 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06609226 · EU 2024-510805-27-00